Oncosec Medical (ONCS) Misses Q4 EPS by 4c
- Wall Street falls as bank, healthcare shares weigh
- Qualcomm (QCOM) Faces U.S. Antitrust Case Over Licensing - Bloomberg
- BAT Reaches Deal to Acquire Reynolds American (RAI) for $49 Billion
- Verizon Communications (VZ) May Acquire Big Cable Company - NYP (CHTR) (CMCSA)
- Citron Research Negative on Lannett (LCI); Sees Shares at 'Zero' Over Long Term
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Oncosec Medical (NASDAQ: ONCS) reported Q4 EPS of ($0.39), $0.04 worse than the analyst estimate of ($0.35).
For earnings history and earnings-related data on Oncosec Medical (ONCS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley (MS) Tops Q4 EPS by 17c
- FBR Capital Remains Sidelined on Comerica (CMA) Following 4Q Report
- IBM (IBM): No Fireworks Needed, Just Evidence of Transition - Drexel Hamilton
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!